Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Details) - Schedule of adjustments on the restated financial statements consolidated balance sheet

v3.22.2
Restatement of Previously Issued Financial Statements (Details) - Schedule of adjustments on the restated financial statements consolidated balance sheet - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
As Previously Reported [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Accounts payable and accrued liabilities $ 43,933  
Other liabilities 81,948 $ 26,585
Total liabilities 371,146 258,304
Redeemable convertible preferred stock (Series A) 194,675  
Additional paid-in capital 723,394 708,175
Accumulated deficit (470,304) (465,264)
Total stockholders’ equity 243,414 233,234
Adjustments [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Accounts payable and accrued liabilities 1,028  
Other liabilities 9,933 11,550
Total liabilities 10,961 11,550
Redeemable convertible preferred stock (Series A) (1,028)  
Additional paid-in capital (1,346) (6,941)
Accumulated deficit (8,587) (4,609)
Total stockholders’ equity (9,933) (11,550)
As Restated [Member]    
Condensed Balance Sheet Statements, Captions [Line Items]    
Accounts payable and accrued liabilities 44,961  
Other liabilities 91,881 38,135
Total liabilities 382,107 269,854
Redeemable convertible preferred stock (Series A) 193,647  
Additional paid-in capital 722,048 701,234
Accumulated deficit (478,891) (469,873)
Total stockholders’ equity $ 233,481 $ 221,684